SLPI Antikörper (AA 11-60)
Kurzübersicht für SLPI Antikörper (AA 11-60) (ABIN6754966)
Target
Alle SLPI Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 11-60
-
Marke
- IHC-plus™
-
Spezifität
- Human SLPI
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa11-60 of human SLPI (P03973, NP_003055). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla (100%), Orangutan, Gibbon, Baboon, Monkey (92%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: IHC, IHC-P (10 μg/mL), WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- SLPI (Secretory Leukocyte Peptidase Inhibitor (SLPI))
-
Andere Bezeichnung
- SLPI
-
Hintergrund
-
Name/Gene ID: SLPI
Synonyms: SLPI, ALK1, ALP, Antileukoprotease, BLPI, HUSI, Mucus proteinase inhibitor, HUSI-I, SLP1, Antileukoproteinase, Seminal proteinase inhibitor, WFDC4, HUSI-1, Protease inhibitor WAP4, WAP4 -
Gen-ID
- 6590
-
NCBI Accession
- NP_003055
Target
-